The company may no longer be operating, as it may be out of business. Find out why through their latest events.

Diffusion Pharmaceuticals Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top 21 shareholders own 9.19% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
3.25%	The Vanguard Group, Inc.	66,232	€462.3k	-8.98%	no data
1.98%	Renaissance Technologies LLC	40,309	€281.4k	3.07%	no data
1.61%	BlackRock, Inc.	32,852	€229.3k	0%	no data
0.84%	Geode Capital Management, LLC	17,123	€119.5k	0%	no data
0.81%	Bridgeway Capital Management, LLC	16,565	€115.6k	0%	no data
0.3%	Dimensional Fund Advisors LP	6,099	€42.6k	0%	no data
0.12%	Tower Research Capital LLC	2,410	€16.8k	-27.4%	no data
0.079%	Robert Cobuzzi	1,616	€11.3k	0%	no data
0.06%	Jane Hollingsworth	1,231	€8.6k	0%	no data
0.053%	Mark Giles	1,075	€7.5k	0%	no data
0.029%	Securities America Advisors, Inc.	587	€4.1k	0%	no data
0.027%	Morgan Stanley & Co. International Plc Investment Account	548	€3.8k	0%	no data
0.02%	William Elder	400	€2.8k	0%	no data
0.014%	Diana Lanchoney	294	€2.1k	0%	no data
0.0035%	Robert Adams	71	€495.6	0%	no data
0.0029%	UBS Asset Management AG	60	€418.7	-87.2%	no data
0.0016%	Alan Levin	33	€230.7	0%	no data
0.00093%	Osaic Wealth, Inc. , Asset Management Arm	19	€132.5	0%	no data
0.00074%	Wells Fargo & Company, Private Banking and Investment Banking Arm	15	€105.4	7.14%	no data
0.00044%	TimeScale Financial, Inc.	9	€62.7	0%	no data
0.00039%	FSC Securities Corporation, Asset Management Arm	8	€55.5	0%	no data